
For at least two decades, the U.S. Food and Drug Administration has been approving new formulations of prescription opioids without requiring drug manufacturers to gather important information on safety and effectiveness, a new study claims. The FDA approved dozens of these highly addictive medications for treatment of chronic pain between 1997 and 2018 based on… read on >